SALTO - Symbicort Single Inhaler Therapy Use in Adolescent Adults and Adults With Persistent Asthma
NCT00290264 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 1000
Last updated 2011-01-24
Summary
The primary objective is to compare the efficacy of Symbicort Single inhaler Therapy with treatment according to conventional best practice in adolescent and adult patients with persistent asthma.
Conditions
Interventions
- DRUG
-
Budesonide/formoterol
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
AstraZeneca Belgium Medical Director, MD · AstraZeneca
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 12 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-12-31
- Completion
- 2006-08-31
Countries
- Belgium
- Luxembourg
Study Locations
More Related Trials
-
MONO: Symbicort® Single Inhaler Therapy and Conventional Best Standard Treatment for the Treatment of Persistent Asthma in Adolescents and Adults
NCT00242411 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Symbicort pMDI Administered Once Daily in Children and Adolescents During 12 Weeks - SPROUT
NCT00646321 ·Status: COMPLETED ·Phase: PHASE3
-
DESOLO - SiT Peri-Launch: A Comparison of Symbicort Single Inhaler Therapy and Conventional Best Practice for the Treatment of Persistent Asthma in Adults
NCT00252863 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Symbicort pMDI Administered Once Daily in Adolescents and Adults During 12 Weeks - STEM
NCT00652392 ·Status: COMPLETED ·Phase: PHASE3
-
A Comparison of Symbicort® Single Inhaler Therapy and Conventional Best Practice for the Treatment of Persistent Asthma
NCT00628758 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Safety and Efficacy of Symbicort® pMDI, With or Without Spacer, in Children (6-11 Years) With Asthma
NCT00536913 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Symbicort Versus Its Monocomponents - SPRUCE 160/4.5
NCT00652002 ·Status: COMPLETED ·Phase: PHASE3
-
Safety & Efficacy of Symbicort® Turbuhaler® (1, 2, and 4 x 160/4.5 µg Twice Daily) in Japanese Patients With Asthma
NCT00255255 ·Status: COMPLETED ·Phase: PHASE3
-
New Breath Actuated MDI Symbicort Compared to Symbicort pMDI and Budesonide pMDI for 12 Weeks Twice a Day
NCT01360021 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of the Efficacy/Safety of Symbicort® Turbuhaler®,Seretide™ Diskus™ 50/500 µg & Terbutaline Turbuhaler® 0.4 mg
NCT00242775 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Investigate the Efficacy of Symbicort® SMART.
NCT00839800 ·Status: COMPLETED ·Phase: PHASE3
-
Symbicort in Asthmatic Children - SEEDLING
NCT00651547 ·Status: COMPLETED ·Phase: PHASE3
-
Symbicort Single Inhaler Therapy for Asthma in a General Practice Setting
NCT00235911 ·Status: COMPLETED ·Phase: PHASE3
-
Randomized, Placebo-Controlled, Multidose, Study Comparing Generic Budesonide/Formoterol Fumarate Dihydrate to Symbicort® in Asthmatic Participants
NCT02495168 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Budesonide / Formoterol Combination in Repeated AMP Provocations
NCT00272753 ·Status: COMPLETED ·Phase: PHASE4
-
A Clinical Study to Evaluate Symbicort Turbuhaler Used 'as Needed' in Adults and Adolescents With Asthma
NCT02224157 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluating the Symbicort Turbuhaler (Formoterol/Budesonide) Maintenance and Reliever Therapy for Asthma in Daily Practice
NCT00782314 ·Status: COMPLETED
-
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
NCT01444430 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Study to Evaluate Symbicort Turbuhaler Used 'as Needed' in Adults and Adolescents With Asthma.
NCT02149199 ·Status: COMPLETED ·Phase: PHASE3
-
Symbicort Turbuhaler 30/60 Clinical Experience Investigation
NCT01232348 ·Status: COMPLETED
-
A 12-Week Study in Asthmatic Children Ages 6 to <12 Years, Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg and Symbicort pMDI 80/4.5 μg, Compared With Budesonide pMDI 80 μg
NCT02091986 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Investigate the Safety and Efficacy of High Dose of Symbicort® SMART in Japanese Patients
NCT00837967 ·Status: COMPLETED ·Phase: PHASE3
-
Randomized, Placebo-controlled, Multi-dose, Study Comparing Budesonide/Formoterol to Symbicort® in Asthmatic Patients
NCT03015259 ·Status: COMPLETED ·Phase: PHASE3
-
Long-Term Safety of Symbicort in Asthmatic Children - SAPLING
NCT00646529 ·Status: COMPLETED ·Phase: PHASE3
-
Cost-effectiveness Study of Symbicort as Maintenance and Reliever Therapy (SMART)
NCT00937066 ·Status: COMPLETED